Biogennix, LLC

Biogennix is a medical device manufacturer specializing in advanced synthetic bone graft products for orthopedic and spinal surgery. The company's core technology platform, TrelCor®, features nano-sized surface architecture designed to optimize cell attachment and promote bone formation. Biogennix offers moldable, hydrated bone graft materials under product lines including Agilon®, engineered to improve surgical outcomes in spinal and orthopedic procedures. The company operates a distributor-based commercial model, partnering with specialized distributors in the spinal surgery space. Products are synthetic bone grafts intended as alternatives to autograft and allograft options, addressing a significant market need in orthopedic surgery where bone graft substitutes are critical for fusion procedures and defect management. Regulatory status and specific 510(k) clearances are not detailed on the accessible website content, though the company markets products as advanced medical devices for clinical use.